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 Cell cycle progression must be tightly coordinated with cell fate 
choice. In this regard, cell division is one of the crucial factors that ensure 
differentiation process, as exemplified by mitotic clonal expansion during 
adipogenesis. However, there is not much of evidence and underlying 
mechanism that help us understand how cell division might play a role in 
other types of differentiation, ensuring controlled tissue development and 
homeostasis. Here, I focused on the involvement of cell division during 
neuronal differentiation. I used retinoic acid (RA)-induced in vitro 
neurogenesis system of P19 embryonic carcinoma cells to examine the direct 
link between cell division and neuronal differentiation. I observed that cell 
cycle blockers inhibited neuronal differentiation of P19 cells. In order to 
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investigate the underlying mechanisms, I screened for RA target genes 
whose transcripts were reduced with cell cycle blockers and identified Tshz1 
as a candidate for the cell division-dependent genes. The promoter analysis 
of Tshz1 found the minimal essential region for RA and cell division-
dependent transcriptional activation. Through computational sequence 
analysis of the promoter, E2F1 was predicted a possible upstream 
transcription factor for Tshz1. Furthermore, the E2F1 binding activity on the 
Tshz1 promoter was reduced with the thymidine treatment. Taken together, 
E2F1 may function as a transcription factor whose activity is controlled in a 
cell division-specific manner for RA induction of Tshz1 expression. This 
study is an example that cell division itself functions as a regulatory 
mechanism to ensure neuronal differentiation. 
Keywords: Stem cell, Differentiation, Cell division, Retinoic acid, Transcription 
factor, Neurogenesis, P19 cell  
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1. Cell cycle control during differentiation 
Since the characterization and isolation of embryonic stem cells, 
understanding the intrinsic and extrinsic factors that control pluripotency of 
stem cells has been the core of stem cell research field. Although the major 
factors essential for pluripotency maintenance (i.e. Yamanaka factors) were 
discovered, it is still poorly understood as to which additional parameters are 
important for a specific cell fate acquisition. Cell cycle is a universal process 
that is displayed by almost all types of cells but its potential role during 
differentiation is only beginning to be revealed. Studying specific functions 
of cell cycle in the context of lineage-specification during differentiation 
may be a key to understanding how stem cells sense and decide to acquire its 
destined fate. In this section, the current understanding link between cell 
cycle and differentiation will be discussed.           
1.1 Cell cycle structure of pluripotent vs. 
differentiated cells 
It has been well reported that undifferentiated stem cells and terminally 
differentiated cells display distinct cell cycle profile. Undifferentiated stem 
cells divide much more rapidly (Hindley and Philpott, 2013), whereas, fully 
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differentiated cells usually exit the cell cycle from G1 to G0 and no longer 
proliferate. Despite much earlier observation, the precise kinetics behind the 
cell cycle change could not be investigated due to technical difficulty.  
Recent innovation in scientific tool, called Fluorescent Ubiquitylation-
based cell-cycle indicator (FUCCI), have allowed to directly test the 
sequential relationship between changes in cell cycle structure and 
differentiation (Sakaue-Sawano et al., 2008). Fluorescent fusion proteins of 
these molecules label cell cycle phase, and this tool allowed to measure 
individual cell’s total cell cycle length and G1 phase length without 
artificially altering the cycle by pharmacological means. Using FUCCI as a 
tool, it is now well recognized that undifferentiated cells have much shorter 
cell cycle length, and differentiation signal quickly results in shorter cell 
cycle length, mainly due to increased G1 phase (Figure 1) (Roccio et al., 
2013). 
1.2 G1 phase during differentiation 
In 1974, Pardee have implicated role of specific cell cycle phase that is 
required for differentiation. The physiological significance of G1 phase was 
implied by demonstrating the existence of Restriction point (R-point) as a 
time point when cell decides to exit the cell cycle or to complete the next 
cycle (Pardee et al., 1974). In 1985, Zetterberg and Larsson have developed 
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the importance of R-point further by showing its role in cell fate acquisition 
(Figure 2). The group have discovered that only the cells in early G1 phase 
exit the cell cycle and become quiescent upon serum deprivation (Zetterberg 
and Larsson, 1985). 
In this view, main efforts were on understanding the link between cell 
cycle and differentiation through G1 phase, and now it is described as a 
window of opportunity for the cells to decide either to self-proliferate or to 
differentiate (Figure 2). A recent study on cell cycle machinery’s role in cell 
fate acquisition provided a mechanistic clue on how G1 phase might affect 
differentiation. Cyclin D-CDK4/6 complex, which regulates G1 phase in 
conventional cell cycle, was found to be a player that also controls signaling 
molecules for lineage-specification at G1 phase (Pauklin and Vallier, 2013). 
The study explains that the early G1 phase is permissive for endoderm 
differentiation, while the late G1 phase is only permissive for neuroectoderm 
specification in hESCs (Vallier, 2015) 
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2. Cell division during differentiation 
In this study, cell division itself was examined for potential regulator of 
differentiation. Due to the popular tendency for researchers to focus on G1 
phase and its length when studying differentiation process, cell division’s 
role was relatively overlooked. Nevertheless, the role of cell division has 
been implicated in differentiation of several systems, such as adipogenesis, 
myogenesis, and activation of specific gene-clusters.   
2.1 Mitotic clonal expansion (MCE) during 
adipogenesis 
Adipogenesis is a differentiation process by which mesenchymal stem 
cells become mature adipocyte containing large cytosolic lipid droplets. 
During in vitro differentiation of 3T3-L1 cells, cells firstly undergo contact 
inhibition and exit the cell cycle to G0, but treatment of cocktail of 
differentiation inducers drive the arrested cells to reenter the cell cycle 
(Figure 3). Several rounds of cell cycle during this process, called mitotic 
clonal expansion (MCE), was understood as an event that is associated with 
adipogenesis but the precise link was unclear.  
To study the process, in vitro differentiation of preadipocyte cell line, 
3T3-L1, was used, and the course of synchronous cell division was directly 
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monitored by time course analysis of total cell number and FACS analysis. 
Time course analysis of total cell number showed that the number doubled 
around 36 hours and quadrupled nearly 60 hours after growth arrest. This 
implied that cells divided once every 30 hours post growth arrest. In parallel, 
time course analysis of DNA content by FACS also showed similar result. 
DNA content was doubled synchronously, which was reduced by half about 
30 hours after growth arrest. This synchronous cell cycle reentry and 
subsequent two to three rounds of cell cycle was called mitotic clonal 
expansion.  
In an attempt to address the requirement of MCE for adipogenesis, the 
biological significance of MCE was confirmed by treatment of Cdk2 
inhibitor, roscovitine, during MCE. The result showed reduced accumulation 
of cytoplasmic content of triacylglycerol and reduced expression of 
adipocyte markers (Tang et al., 2003). Therefore, in adipogenesis, the 
importance of MCE lied in ensuring functional differentiation of L1 cells 
into adipocytes because cell cycle block or inhibition of MCE resulted in 
inhibited adipogenesis. In fact, expression of essential upstream master 
regulators, such as, C/EBP beta, delta, alpha, and PPAR-gamma that control 
the expression of downstream adipocyte genes was known as the most direct 
way to control adipocyte differentiation. These studies suggest that MCE 
controls adipogenesis at an upstream level by acting as a licensing factor for 
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the progression of adipogenesis.  
Time course analysis of EMSA assay using consensus C/EBP beta 
binding DNA sequence and nuclear extracts showed that C/EBP beta, one of 
the upstream regulators, is expressed early during differentiation, which 
acquire DNA binding activity after G1-S transition during MCE (Tang and 
Lane, 1999). DNA binding activity, which is essential for the expression of 
other important downstream factors, is only gained after C/EBP beta is 
phosphorylated by GSK-3beta and subsequently by Cdk2 (Li et al., 2007). In 
this respect, completion of cell divisions functions as licensing factor that 
allows for transcriptional cascade, which is required for completion of 
differentiation process. 
2.2 Cell proliferation during myogenesis 
Myogenesis is another differentiation process that results in 
development of muscle cells. In a study that aimed to find how myogenic 
activation by Lbx1 and Pax3 is controlled, it was discovered that 
overexpression of Lbx1 and Pax3 resulted in both increased cell proliferation 
and upregulation of their downstream myogenic targets. The importance of 
cell proliferation was suggested when blocking Lbx1 and Pax3-dependent 
cell proliferation resulted in a complete lack of myogenic markers MyoD, 
myogenin and myosin heavy chain despite overexpression of Lbx1 and Pax3 
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(Mennerich and Braun, 2001). Unfortunately, the study did not focus on 
further investigating molecular mechanism related to cell proliferation the 
reason why cell proliferation is needed during myogenesis needs to be 
further investigated. Nevertheless, it is still a good example that expression 
of master regulator is not sufficient for differentiation and that cell 
proliferation is also needed for the process. 
2.3 DNA replication and temporal gene 
activation  
As mentioned above, differentiation is an intricate process that requires 
not only the transcriptional activation of factors, but also a controlled 
interplay between these factors. To ensure the well-scheduled expression of 
factors, transcriptional activation of early developmental gene has been 
suggested to be linked to cell cycle through DNA replication. This potential 
link may explain how cells control sequential expression of development-
related genes. HoxB, a homeobox gene that is important for body patterning, 
is expressed very early during development and their gene expression was 
observed to convey temporal collinearity in RA-induced P19 cells (Fischer 
and Mechali, 2003), which was abolished upon inhibition of DNA 
replication. This result showed that, in synchronized P19 cells, HoxB genes 
are linked to developmental transcriptional control through the cell cycle by 
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being activated within the first round of cell cycle, especially during S phase. 
3. Neuronal differentiation of P19 cells 
In this study, P19 cells were used as a model system to study the 
molecular mechanism underlying the role of cell division during neuronal 
differentiation. The main advantage of using P19 cells for this study lies in 
well-defined in vitro culture condition for efficient neuronal differentiation. 
Moreover, differentiation of P19 cells resembles that of early development. 
Treatment of retinoic acid in P19 cells not only results in functional neurons 
and glial cells, but also the differentiation adequately represents in vivo 
neurogenesis and gliogenesis process.    
3.1 P19 embryonic carcinoma cells  
P19 cell is murine embryonal carcinoma cell, pluripotent stem cells of 
malignant teratocarcinomas, which can efficiently differentiate into neurons 
in the presence of retinoic acid (RA). P19 cells were originally derived from 
a teratocarcinoma, which was formed by transplanting C3H/He mouse 
embryo into a host mouse testis (McBurney MW and Rogers BJ, 1982).  
With appropriate culture condition, P19 cells can be induced to differentiate 
into embryonic body (EB) with cell types of three germ layers (ectoderm, 
endoderm, or mesoderm). Because of its well characterized condition for 
specific type of differentiation, well-representation of in vivo early 
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differentiation process, and relatively convenient in vitro culture system, it is 
widely used as a useful system to study differentiation in vitro (Jones-
Villeneuve et al., 1982).  
3.2 Retinoic acid-induced transcription 
Retinoic acid (RA) is one of the major vertebrate lipophilic morphogens 
that is essential for the correct patterning during early embryogenesis. It is 
known that RA controls expression of gene cluster known as homeobox 
genes during anterior-posterior (A-P) patterning (Simeone, A. et al, 1995).  
RA is signaling molecule that exerts its action through different types of 
retinoic acid receptors (RARs). These ligand-dependent transcription factors 
then act in heterodimeric combinations with one of the retinoid X receptors, 
which together bind to specific DNA sequence of RA-reponse elements 
(RAREs) (Niederreither and Dollé, 2008). (Figure 4) 
3.3 Studying the role of cell division in P19 
cells 
Previous studies have shown that RA-induction in P19 cells occurs 
mainly in G1 phase. However, the study also implied that RA-induction at 
G1 phase alone is insufficient for commitment to occur, which was also 
demonstrated using mouse embryonic stem cells (ESCs) (Li et al., 2012). In 
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RA-induced differentiation, P19 cells need at least 24 hours to fully commit 
to differentiate and few rounds of cell cycle were implicated as important 
events (Mummery et al., 1987). 
Despite many additional studies on roles of cell cycle in stem cell 
differentiation, it is still unclear as to why certain events are necessary during 
the initial 24 hours after RA induction. Therefore, this study attempts to 
answer the unexplored question on the requirement of several rounds of cell 
cycle during early hours of RA treatment for cells to differentiate. In this 
study, the main goal is to investigate role of cell division during RA-induced 
neuronal differentiation of P19 cells. Identification of specific cell division-
dependent differentiation regulator will open a new doorway to understand 


















Figure 1. G1 phase lengthening upon differentiation.  During 
differentiation, cell cycle characteristics of stem cells undergo drastic 
changes. Differentiation signal-induced cells acquire much longer G1 phase 
(labeled in red color), resulting in an increased total cell cycle length (Roccio 







Figure 2. Current model on how cell cycle drives differentiation of stem 
cells. (A) G1 phase is characterized by Restriction point (R-point). R-point 
divides G1 phase into early and late G1 phases and marks a point of no 
return for the cells. Once cells pass through R-point of G1 phase, cells are 
committed to complete the cycle (Orford and Scadden, 2008). (B) Recent 
studies show how lineage specification occurs during G1 phase. Early G1 is 
responsible for endoderm and late G1 is responsible for neuroectoderm 
lineage specification. Following studies also suggested that subsequent cell 


























Figure 3. Mitotic Clonal Expansion (MCE) during adipocyte 
differentiation.  During adipogenesis, cell cycle-arrested cells undergo 
synchronous cell division known as MCE. This process is understood as 
licensing process for cells to complete adipogenesis. (modified from 
































Figure 4. RA-dependent transcriptional control. RA acts as a ligand for 
several nuclear receptors, combinations of which form heterodimers. The 
complex then binds to a RARE (RA-response element), thereby directly 





















Cell cycle progression must be tightly coordinated with cell fate 
choice. In this regard, cell division is one of the crucial factors that ensure 
differentiation process, as exemplified by mitotic clonal expansion during 
adipogenesis. However, there is not much of evidence that the cell division 
also plays a role in other types of differentiation. Here, I focused on the 
involvement of cell division during neuronal differentiation. I used retinoic 
acid (RA)-induced in vitro neurogenesis system of P19 embryonic carcinoma 
cells to examine the direct link between cell division and neuronal 
differentiation. I observed that cell cycle blockers, such as thymidine and 
RO3306, inhibited neuronal differentiation of P19 cells. In order to 
investigate the underlying mechanisms, I screened for RA target genes 
whose transcripts were reduced with cell cycle blockers and identified Tshz1 
as a candidate for the cell division-dependent genes. The promoter analysis 
of Tshz1 found that the 50 bp region at -1250/-1200 are minimal essential 
region for RA and cell division-dependent transcriptional activation. 
Through computational sequence analysis of the promoter, E2F1 was 
predicted a possible upstream transcription factor for Tshz1. In fact, 
endogenous Tshz1 transcript levels were enhance in E2F1-overexpressing 
P19 cells, whereas they were reduced in the E2F1-depleted cells. Specific 
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binding of E2F1 on the Tshz1 promoter was confirmed with the 
electrophoretic mobility shift and chromatin immunoprecipitation analyses. 
Furthermore, the E2F1 binding activity on the Tshz1 promoter was reduced 
with the thymidine treatment. Taken together, E2F1 may function as a 
transcription factor whose activity is controlled in a cell division-specific 
manner for RA induction of Tshz1 expression. This study is an example that 





















Differentiation is an intricate process by which uncommitted cells 
acquire its cell fate. It has been widely accepted that expression of key 
master regulators (i.e. transcription factor) or external stimuli are common 
ways for stem cells to differentiate but stochastic differentiation and 
heterogeneous cell fate of stem cell could not be explained. Recently, 
unusual mode of cell cycle regulation of stem cells became the main focus in 
the research field. Cells undergoing differentiation display distinct cell cycle 
structure of lengthened G1 phase and no longer divide after terminal 
differentiation (Coronado et al., 2013; Hindley and Philpott, 2013). Many 
studies were based on the idea that G1 phase may act as a gateway to 
integrate differentiation signal into cell fate acquisition (Coronado et al., 
2013; Pauklin and Vallier, 2013; Pauklin et al., 2015; Singh et al., 2013). 
Despite the importance of a specific cell cycle phase on the induction of 
differentiation signal, lengthening G1 phase is not sufficient for the induction 
of differentiation (Li et al., 2012). In RA-induced differentiation, P19 cells 
need at least 24 hours to fully commit to differentiate and several rounds of 
cell cycle were implicated as important events (Mummery et al., 1987). In 
this aspect, cell division is not a mere way for cells to expand but another 
potentially important event that regulates differentiation as seen in 
21 
 
adipogenesis, myogenesis, and early embryo development, but the 
underlying molecular mechanisms has not been fully investigated. 
Several lines of evidence support the link between cell division and 
differentiation. Cell division is a common process by which mother cell 
gives rise to genetically identical two daughter cells. On a multicellular level, 
the role of cell division is much more complex as it occurs not just to 
produce clones but to organize the tissue. It is frequently adopted to produce 
more specialized cells, such as gametes. Through cell division, cells 
collectively control cell growth, cell morphology, as well as tissue 
development.  
The role of cell division during differentiation has been implicated in 
tissue development. In tissues, spindle assembly and morphology are 
coordinated to control mode of cell division so that specific cell types are 
made (Dudka and Meraldi, 2017). During development of cerebral cortex, 
cells need to be both expanded and differentiated to reserve specific cell 
population. Stem cells undergo specialized division known as symmetric 
self-renewing division and asymmetric neurogenic division to maintain a 
pool of both neural stem cells and neural progenitor cells. While symmetric 
division results in expansion of neural stem cells, they later undergo 
asymmetric division. One of the daughter cells remains a proliferating 
progenitor and the other become neuron after one or multiple rounds of 
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transit amplifying divisions (Homem et al., 2015). In this way, early 
proliferative divisions are necessary for the expansion of progenitor pool, 
and the timing of the switch to later asymmetric or symmetric divisions 
determines the development of different regions of the brain (Hardwick and 
Philpott, 2014). In this way, role of cell division is tightly linked to a normal 
development of tissue, thus, homeostasis of an organism.  
In other cases, cell division acts as a way to directly regulate 
differentiation process by controlling the expression of lineage specific genes. 
Mitotic clonal expansion (MCE) is a type of specialized cell division that is 
known as a prerequisite for adipocyte differentiation (Tang and Lane, 2012). 
MCE is required for activation of C/EBPß and expression of C/EBPα and 
PPARγ, both of which are essential for ensuring adipocyte differentiation. 
MCE is two to three rounds of synchronous cell division that sequentially 
take place upon hormonal induction, which signals the onset of adipogenesis. 
It functions as licensing factor that allows for transcriptional cascade, which 
is required for the completion of adipocyte differentiation process (Tang et 
al., 2003). Similar function of cell division is also reported relating 
transcriptional regulation of Hox family gene which is known as important 
factor during early development. HoxB body pattern-related genes are linked 
to developmental transcriptional control through the cell division by being 
activated within the first round of cell cycle after differentiation (Fisher and 
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Mechali, 2003). These controlled differentiation processes partially explain 
why terminal cell fate acquired cells no longer divide. Nevertheless, these 
still do not explain why differentiating cells need to undergo multiple rounds 
of cell division before acquiring its final state of differentiation. 
Heterogeneity in pluripotent stem cells is repeatedly observed but its 
nature has not been fully understood (Singh et al., 2013). Because stem cells 
have particularly high heterogeneity on a population level, it is difficult to 
examine a single mechanism that collectively controls gene expression 
during differentiation. In order to decipher the direct link between cell 
division and differentiation, a single population of cell line can be a useful 
tool. As shown by Sawano and his colleagues who analyzed cell cycle of 
developing neural tissues using Fucci transgenic mice, cells in brain tissue 
display spatiotemporal dynamics (Sakaue-Sawano et al., 2008). Despite the 
powerful images of the link between cell cycle and differentiation in vivo, 
there is still a lack of mechanistic understanding at molecular level. 
P19 cell is murine embryonal carcinoma cell, pluripotent stem cells 
of malignant teratocarcinomas, which can efficiently differentiate into 
neurons in the presence of retinoic acid (RA). It is widely used as a 
convenient system to study differentiation in vitro,which sufficiently 
represents in vivo neurogenesis process of mouse brain (Jones-Villeneuve et 
al., 1982). Previous studies have shown that RA-induction in P19 cells 
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occurs mainly in G1 phase. However, the study implied that RA-induction at 
G1 phase alone is insufficient for commitment to occur, which was also 
demonstrated using mouse embryonic stem cells (mESCs) (Li et al., 2012).  
Despite many additional studies on the role of cell cycle in stem cell 
differentiation, it is still unclear as to why certain events are necessary during 
the initial 24 hours after RA induction. To help understand this process, I 
looked carefully into the old paper (Mummery et al., 1987) and revisited the 
question on the requirement of several rounds of cell divisions during early 
hours of RA induction for cells to differentiate into neurons.  
In this study, I investigated the role of cell division during RA-
induced neuronal differentiation of P19 cells. Time-course cell cycle analysis 
and neurite outgrowth assay implied the requirement of cell division during 
early hours of neuronal differentiation for neurogenesis and neurite 
formation. Furthermore, screening for cell division-dependent genes among 
RA-induced genes by RT-PCR identified several genes whose expressions 
are reduced upon inhibition of cell division. Among the candidates, Tshz1, a 
DNA binding zinc finger protein, was selected for in-depth study. Promoter 
analysis of Tshz1 revealed a specific region that is necessary for RA and cell 
division-dependent transcriptional regulation. Furthermore, using sequence 
specificity results from EMSA mutation assays and computational analysis, 
E2F1 was examined as a potential upstream transcription regulator that 
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activates Tshz1 transcription in a RA and cell division-dependent manner. 
EMSA supershift assay, E2F1 overexpression followed by Tshz1 
transcription analysis, and ChIP assays using anti-E2F1 support that E2F1 
may positively regulate Tshz1 transcription in RA-induced P19 cells. To my 
knowledge, this is the first evidence directly linking cell division to 
differentiation and identification of specific cell division-dependent 
differentiation regulator will open a new doorway to understand cell 



















Materials and Methods 
Antibodies 
 The antibodies against Tuj1 (Covance, MMS-435p-100), phospho-
histone-H3 (Upstate), p27 (Abcam, ab7961), E2F1 (Santa Cruz 
Biotechnology, sc-251), GFP (Santa Cruz Biotechnology, sc-9996), Flag 
(Sigma-Aldrich, F3165) GAPDH (Ambion, AM4300) were commercially 
purchased. The Alexa-fluorescence secondary antibodies were purchased 
from Invitrogen. The mouse and rabbit IgG-HRP antibodies were purchased 
from Sigma and Millipore, respectively.   
 
Cell culture and drug treatment 
P19 embryonic carcinoma cells were cultured in DMEM (Welgene) 
supplemented with 10% FBS and antibiotics (5 μg/ml ANT-MPT; 
InvivoGen) at 37˚C and 5% CO2. The single thymidine block method was 
used to synchronize the cell cycle. The cells were treated with 2 mM of 
thymidine for 12 h and released after cells were PBS washed at least twice. 
For G2 arrest, the cells were treated with RO3306 (10 μM) for 12 h. 
For depletion of endogenous E2F1 and Tshz1, siE2F1-1 (5′-CGC 
UAU GAA ACC UCA CUA ATT-3′) and siE2F1-2 (5′-GUG GAU UCU 
UCA GAG ACA UTT-3′) and siE2F1-3 (5′-GAG GGC AUU AGA GAU 
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CUC UTT-3′) and siTshz1 (5′-CCC AGA UAC UCA AGU GCA UTT-3′) 
were used. A scrambled siRNA sequence (siCTL; 5′-UUC UCC GAA 
CGU GUC ACG UTT-3′) was used as a control. RNAiMAX (Invitrogen, 
13778-075) was used for siRNA transfection according to the 
manufacturer’s protocol. 
 
In vitro neuronal differentiation 
 The conventional method was performed essentially according to the 
previous report (McBurney et al., 1988). Briefly, P19 cells (1.0 × 105 
cells/mL) were cultured in suspension in a Petri dish in DMEM containing 
and treated with 1µM all trans-retinoic acid (R2656 Sigma) to allow the 
development of embryonic bodies (EBs). The EBs were then trypsinized and 
replated into a poly-l-lysine-coated tissue culture dish and cultured in FBS-
free B27-supplemented DMEM medium (Gibco). 
 
Immunocytochemistry analysis 
 P19 cells were seeded on cover glass were fixed with cold methanol 
for 10 min and washed three times with cold PBS. After incubation of PBST 
(0.1% Triton X-100 in PBS) for 10 min, the cells were blocked with 
blocking solution (3% bovine serum albumin, and 0.3% Triton X-100 in PBS) 
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for 30 min. Then cells were incubated with primary antibodies diluted in 
blocking solution for 1 h, washed three times with PBST, incubated with 
secondary antibodies in blocking solution for 30 min. Afterwards, cells were 
washed twice with PBST, incubated with 4,6-diamidino-2-phenylindole 
(DAPI) solution for 3 min and washed twice with PBST. The cover glasses 
were mounted on a slide glass with ProLong Gold antifade reagent (Life 
Technologies, P36930). Images were acquired from fluorescence 
microscopies equipped with digital cameras (Olympus IX51 equipped with 
QImaging QICAM Fast 1394 or Olympus IX81 equipped with ANDOR 
iXonEM+) and processed in ImagePro 5.0 (Media Cybernetics). Inset images 




 Cells were lysed on ice with RIPA lysis buffer (150 mM NaCl, 1% 
Triton X-100, 0.5% sodium deoxycolate, 0.1% SDS, 50 mM Tris-HCl at pH 
8.0, 10 mM NaF, 1 mM Na3VO4, 1 mM EDTA and 1 mM EGTA) 
containing a protease inhibitor cocktail (Sigma-Aldrich, P8340). The cell 
lysates (30 μg protein) were loaded onto a SDS-polyacrylamide gel and 
transferred onto nitrocellulose membranes (GE healthcare).  
 
RT-PCR 
 Total RNAs were extracted using Trizol (Invitrogen) and reverse 
transcription was performed from 2 μg total RNAs using RnaUsScript RT 
(LeGene). The abundance of mRNA was detected by an ABI prism 7500 
system with SYBR TOPreal qPCR 2× PreMix (Enzynomics). The quantity 
of mRNA was calculated using the ΔΔCt method and Beta-actin, Gapdh and 
Hmbs were used as control. 
 
Luciferase assay 
 A promoter reporter construct containing -1500 to +500 relative to 
TSS of Tshz1 promoter was inserted upstream of the Firefly luciferase 
reporter in the pGL3-Basic vector (Promega). To make stable cell line of 
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luciferase reporter, neomycin (kanamycin) - expressing sequence was 
inserted. 24 h after transfection of these constructs, P19 cells were subjected 
to G418 selection for 1 week. Then, polyclonal cell lines were subjected to 
luciferase assays using microplate luminometer (DE/LB 96V, Berthold 
Technologies). For construction of Tshz1 mutants, site-directed mutagenesis 
was performed. Luciferase outputs were normalized by total protein amount 
measured by Bradford assay. All values were calculated as relative to pGL3 
vector. 
 
 EMSA assay 
 The oligonucleotides were first biotinylated and annealed, using the 
Biotin 3’End DNA labeling Kit (Thermo Fisher Scientific, Rockford IL, 
USA). Nuclear extracts were prepared from P19 cells using nuclear 
extraction buffer. Binding reactions were performed using the LightShift 
Chemiluminescent EMSA Kit (Thermo Fisher Scientific, Rockford, IL, 
USA). The reactions were performed on ice for 20 min with nuclear extract 
and 10 fmol of labeled DNA in a final volume of 20 l, containing 2 l of 
10x binding buffer, and 1 l of Poly (dI.dC). For supershift assays, 1-3 g of 
E2F1 antibody (Santa Cruz Biotechnology) was added to the reaction 
mixture described above, followed by incubation on ice for 15 min prior to 
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the addition of the labeled oligonucleotide probe. For all the supershift 
assays, DTT-free buffers were used. The resultant DNA-protein complex 
was resolved from free oligonucleotide in a 6% native polyacrylamide gel in 
Tris borate–EDTA buffer, and transferred to nylon membranes (Biorad). The 
membranes were cross-linked by UV radiation using Gel-doc (Bio-Rad 
Laboratories). Biotin signals were detected using a Chemiluminescent 
Nucleic Acid Detection Module (Thermo Fisher Scientific) in accordance 
with the manufacturer’s instructions. A double-stranded mutated 
oligonucleotide and unlabeled double stranded oligonucleotides were used to 
examine the specificity of DNA binding. 
 
FACS analysis 
 Samples were collected over indicated time points and fixed in 70% 
ethanol overnight. For cell cycle analysis, fixed cells were treated with 
RNase for 20 minutes before addition of 5g/mL propidium iodide (PI) and 
analyzed by FACS (BD Biosciences FACScalibur). 
 
Chromatin immunoprecipitation assay 
 P19 cells were crosslinked with 13% formaldehyde for 10 min at 
room temperature. After glycine quenching, the cell pellets were lysed in 
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buffer containing 50 mM Tris-HCl (pH 8.1), 10 mM EDTA, 1% SDS, 
supplemented with complete protease inhibitor cocktail (Roche), and 
sonicated. Chromatin extracts containing DNA fragments with an average of 
250 bp were then diluted ten times with dilution buffer containing 1% Triton 
X-100, 2 mM EDTA, 150 mM NaCl and 20 mM Tris-HCl (pH 8.1) with 
complete protease inhibitor cocktail, pre-cleared with protein A/G sepharose 
and subjected to immunoprecipitations overnight at 4°C. Immunocomplexes 
were captured by incubating 45 μl of protein A/G sepharose for 2 h at 4°C. 
Beads were washed with low-salt wash buffer (0.1% SDS, 1% Triton X-100, 
2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 150 mM NaCl), high-salt wash 
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 
8.1), 500 mM NaCl), buffer III (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 
10mM Tris-HCl (pH 8.1), 1mM EDTA), TE buffer (10mM Tris-HCl (pH 
8.0), 0.5M EDTA) and eluted in elution buffer (1% SDS, 0.1 M NaHCO3). 
The supernatant was incubated overnight at 65°C to reverse-crosslink, and 
then digested with RNase A for 2h at 37°C and proteinase K for 2h at 55°C. 
ChIP and input DNA were then purified and analysed for PCR analysis. 
 
Neurite outgrowth assay 
 Typically, pictures of 30-50 neurons from three separate coverslips 
from each experiment were taken using a fluorescent microscope (Leica 
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DMI6000B). Representative cells with strong Tuj1 immunoreactivity 
labeling neurite (axonal and dendritic) processes were analyzed. Neurites 
that had lengths that were at least twice the diameter of the cell body were 
measured. Neurite lengths from the cell body and cell body diameter were 
traced and measured using Neuron J (Image J) software and the data were 
compiled and analyzed using Prism (GraphPad). 
 
Statistical Analysis 
 All experiments were performed independently at least three times. 
Values are expressed as mean±S.D. Significance was analyzed using two-
tailed, unpaired t-test, and one-way ANOVA. p<0.05 was considered 


















Cell division control at an early stage of neuronal 
differentiation in P19 cells 
To study the role of cell division during differentiation, I examined 
if there is a time-dependent changes in cell division rate during neuronal 
differentiation. First, time-course analysis of cell division after RA-induction 
was performed. To do this, P19 cells were suspension cultured with RA to 
form embryonic body (EB) and the total cell number was quantified using 
hemocytometer every 24 hours for 4 days (Figure 5A). The result showed 
that total cell number increased with time, indicating that majority of cells 
actively divide until 48 hours after RA induction. Then, total cell number 
plateaued from 72 hours with a slight decrease at 96 hours time-point but the 
reduction level was not statistically significant. Next, percentage of mitotic 
cells were quantified by immunostaining for phosphorylated histone H3-
positive cells (Figure 5B) to see if similar time point change in number of 
mitotic cells correlates with the above result. The result showed that 30% of 
cells undergo mitosis until 48 hours post RA induction, after which 
decreased to about 10%. Together, these results show that cells actively 
divide until 48 hours and expanding cell numbers decrease from around 48 
hours after RA induction in P19 cells. 
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To understand the overall pluripotent and proneural state during 
neuronal differentiation, P19 cells were treated with RA and induced to form 
EB for 4 days. Then, expression level of pluripotency markers, Oct3/4 and 
Sox2, proneural markers, Nestin and Ascl1 were measured. The result 
showed that pluripotency is lost quickly, within 24 hours of RA treatment 
(Figure 6A,B), whereas proneural markers are upregulated gradually and 
relatively later during RA-induction (Figure 6C,D). Overall, the result 
indicated that cells are gradually undergoing neuronal differentiation. 
As reported by many researchers, one of the distinct features of cells 
undergoing differentiation is a dramatic increase in G1 phase length (Roccio 
et al., 2013). To see if decrease in cell division rate is accompanied by 
altered cell cycle structure, time-course cell cycle profile was analyzed using 
FACS analysis (Figure 7A). FACS result showed that G1 phase cells 
increase after RA-induction, whereas S phase and G2/M phase cells decrease 
overtime. Cells in G1 phase dramatically increased 48 hours post RA 
induction, which is similar time point to the change in total cell number 
(Figure 7A).  
It is well known that cells arrested at G1 phase exit to G0 phase in 
order to terminally differentiate (Cheung and Rando, 2013). Tumor 
suppressor p27Kip1 is one of the natural CDK inhibitors that negatively 
regulates cell cycle progression at G1 phase. It has been previously reported 
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that p27Kip1 is a key mediator of growth arrest in RA-induced neuronal 
differentiation using other cell lines (Matsuo and Thiele, 1998; Cuende et al., 
2008).  To see if increase in G1 phase cells represents an increase in cells 
undergoing cell cycle arrest, protein level of stable p27Kip1 was measured by 
immunoblot (Figure 7B). The protein level of p27Kip1 showed that there is a 
dramatic increase of cells undergoing G1 arrest, which occurs soon after the 
time-point when G1 phase cells start to increase. Taken together, these 
results imply that, after RA-induction, cell divisions gradually slow down at 
an early stage of neuronal differentiation in P19 cells. 
 
Importance of cell division at an early stage of differentiation 
for neuronal differentiation and neuron morphogenesis 
Having seen the change in cell division rate followed by increase in 
G1 length and cell cycle arrest during neuronal differentiation, I next 
investigated to see if this change was also linked to neuron formation and 
maturation. To do this, a time-course analysis of neurite outgrowth was 
performed to check if changes in cell cycle dynamics affect the cells final 
state of neuronal differentiation and neuron maturation. Neurite outgrowth 
measurement is way by which neuron formation is assessed. It involves a 
quantification of neurite formation that can be done by measuring neurite 
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length and number of branches (Filous and Silver, 2016). First, cells were 
treated with RA for different number of days. Then, cells were enforced to 
undergo neurogenesis by forming extended neurites. Using neuron-specific 
ßⅢ-tubulin Tuj1 as neuron marker, neurite outgrowth assay of Tuj1-positive 
neurons was quantified using Neuron J (Figure 8).  
The immunostaining result of Tuj1-positive neurons showed that 
very few cells form extended neurites and robust neurite formation is seen 
from 48 hours post RA-induction (Figure 9). In order to see in detail if this 
affects not only neuron formation, but also neuron maturation, neurite length 
and branching were also quantified. The results showed that percentage of 
cells with primary neurites and neurite length dramatically increased from 48 
hours after RA-induction (Figure 10A,B). Further analysis of neurites 
showed that longer hours post RA-induction resulted in similar neurite length 
but more mature neurons with extended branching (Figure 10). Along with 
time-course cell cycle dynamics analysis, these results implied that sufficient 
number of cell divisions during early hours post RA-induction may be 
important for cells to undergo neurogenesis and neuron maturation.  
To directly test the requirement of cell division for neuronal 
differentiation, cell division was blocked by thymidine treatment, a cell cycle 
blocking drug, along with RA. After 48 hours of RA-treatment, cells were 
enforced to undergo neurogenesis. After 3 days of neuronal differentiation, 
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cells were analyzed by neurite outgrowth assay (Figure 11). The result 
showed a dramatic decrease in number of cells with neurites. This indicates 
that cell divisions during early stages of neuronal differentiation are 
important for neuronal morphogenesis. Overall, these results implied a 
strong link between cell division during 48 hours post RA induction and 
neuronal differentiation (Figure 12). 
 
Identification of RA-induced genes that are regulated in a cell 
division-dependent manner in P19 cells  
In order to understand how cell division could control differentiation, 
mechanistic study was performed. One of the common ways by which cells 
control differentiation is transcriptional regulation of lineage-specific genes. 
Therefore, I set up an experimental scheme to see if cell division could 
regulate differentiation process by transcriptional regulation. To test this idea, 
a list of RA-induced genes was made based on the data from previously 
published papers (Tanoury et al., 2014; Mahony et al., 2011; Balmer and 
Blomhoff, 2002), and 38 candidate genes were tested for cell division-
dependency.  
First, to confirm their RA-induced transcriptions, cells were treated 
with or without RA and mRNA expression was analyzed via RT (Reverse 
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Transcription) -PCR. Thymidine was treated along with RA to see the effect 
of blocking cell division on transcription and mRNA level was measured in 
parallel (Figure 13). The RT-PCR result showed that most of the genes tested 
were strongly induced by RA in P19 cells, confirming that referenced papers 
data indeed include legitimate RA target genes (Figure 14). Also, most of the 
genes showed strong transcriptional induction within 24 hours of RA 
treatment, however, the induced genes may be RA direct or indirect target 
genes. Next, to test for cell division-dependency, P19 cells were also treated 
with thymidine to block cell division (Figure 14). For the subsequent in-
depth study, 6 genes were selected out as they were up-regulated by 
thymidine treatment alone and were involved in RA metabolism. Finally, the 
results identified 11 cell division-dependent genes whose expressions were 
decreased with the thymidine treatment (Figure 14B). These candidates were 
further categorized to select for the gene that is suitable for further studies 
and, as a result, Tshz1 was selected. 
To further confirm RA-induced Tshz1 expression with or without 
cell division, qPCR was performed using two different types of cell cycle 
blocking drugs, thymidine and RO3306 (CDK1 inhibitor, G2/M phase 
arresting drug) (Figure 15B). The result was consistent with the RT-PCR 
result and Tshz1 expression was reduced by half when treated with either 
thymidine or RO3306. To see the cell division-dependent expression pattern 
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of Tshz1 more in detail, time-course analysis Tshz1 mRNA was performed 
by synchronizing cells at G1/S phase (Figure 14A,C). RA was treated upon 
cell cycle release and samples were collected every 3-6 hours. The result 
showed that Tshz1 expression is strongly induced soon after first round of 
cell cycle after RA treatment, considering that P19 cell’s doubling time is 
about 12 hours (Figure 15B). This expression pattern also suggests that RA-
induced Tshz1 expression is linked to cell division. 
Tshz1 is a transcription factor with zinc finger motif. Although 
Tshz1 had been known to be involved in trunk patterning during Drosophila 
development, in mouse, it was suggested that it is required for olfactory bulb 
neurogenesis (Ragancokova et al., 2014). Conditional Tshz1 KO mice in 
central and peripheral nervous system showed that it results in deficient 
sense of smell due to inability for progenitor cells to exit the cell cycle to 
become post-mitotic neuron. Since RA-induced differentiation of P19 cells is 
a well-known condition for neuronal differentiation (Jones-Villeneuve et al., 
1982), these previous reports suggest that Tshz1 might also be involved in 
neurogenesis of RA-induced P19 cells. If cell division-dependent Tshz1 
expression upon RA-induction is one of important signaling pathways 
linking cell division to neuronal differentiation, RA-induced Tshz1 
expression itself could be important for neurogenesis. To test this possibility, 
Tshz1 was depleted using siRNA targeting Tshz1 mRNA and cells were 
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induced to undergo neurogenesis (Figure 16A). Neurite outgrowth assay 
showed that Tshz1 depletion (Figure 16B) resulted in reduced percentage of 
cells with primary neurites (Figure 16C,D). Although the reduced level was 
not dramatic, comparison with the control group was statistically significant, 
suggesting that expression of Tshz1 might be necessary, but not sufficient for 
neuronal differentiation.  
 
Identification of Tshz1 promoter region that is important for 
RA and cell division-dependent activation  
So far, qPCR and RT-PCR results consistently showed that Tshz1 
expression is induced by RA, which is reduced when cell division is blocked. 
However, it is still unknown how this phenomenon is occurring at molecular 
level. In order to understand how Tshz1 expression level is being reduced 
upon treatment of cell cycle blocking drugs, promoter region of Tshz1 gene 
was cloned from P19 cells (Figure 17A) and analyzed using luciferase assay 
system (Figure 17B).   
To reconfirm previous qPCR result, luciferase vectors were stably 
expressed in P19 cells. Then, the cells were treated with RA for 24 hours and 
sampled to measure luciferase activity as an indication of promoter activity. 
Luciferase assay result showed that -1500 bp to +500 bp relative to TSS 
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(transcription start site) region of Tshz1 promoter is strongly activated by RA 
(Figure 17B). Consistent with qPCR result, transcriptional activity was 
reduced by half when cell division was blocked by thymidine treatment 
(Figure 17B). This result suggested that promoter activity of Tshz1 gene can 
be activated by RA and may be regulated in a cell division-dependent 
manner.  
Next, to further identify minimal essential region of Tshz1 promoter 
that is responsible for cell division-dependent and RA-induced transcription, 
serial deletion mutants were constructed and analyzed using the same 
luciferase assay (Figure 18A). The result indicated that there is still a strong 
activity with -1300 to +500 bp promoter region but a dramatic decrease in 
promoter activity was observed when there was only -1100 to +500 bp 
region. To see if presence of -1400 to -1200 bp regions is sufficient for 
promoter activity, fragments of Tshz1 promoter were fused to TK (thymidine 
kinase) promoter and luciferase assay was performed (Figure 18B). Series of 
assays using additional mutant constructions indicates that main essential 
region seems to be present within -1250 to -1200 bp of promoter region. 
Furthermore, -1250 to -1200 bp of promoter region alone was sufficient to be 
activated by RA, and cell division block also reduced promoter activity of 
this minimal region by half (Figure 19). These implied that -1250 to -1200 
bp region is responsible for RA-induced transcription and its transcription is 
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being controlled via cell division-dependent pathway. 
 
Putative transcription factors may bind to the -1250/-1226 
sequence of Tshz1 promoter in a RA and cell division-
dependent manner 
In order to further elucidate cell division-dependent control of 
neuronal differentiation, the next step was to search for a transcription factor 
that directly links cell division to neuronal differentiation by controlling 
Tshz1 transcription at an upstream level. Having identified the minimal 
essential region of Tshz1 promoter during RA-induced transcriptional 
activation, it was hypothesized that there is a factor that binds to -1250 to -
1200 bp region in a nucleotide sequence-specific and cell division-dependent 
manner upon RA-treatment. 
First, to test this possibility, Electrophoretic Mobility Shift Assay 
(EMSA) using P19 cells protein lysates and biotinylated -1250 /-1200 bp 
probe was performed to see if there is a candidate nuclear protein binding to 
the region upon RA treatment in a cell division-dependent manner (Figure 
20). The EMSA result showed a strong retarded band, an indication of 
protein binding to the probe, only in a group mixed with RA-treated nuclear 
extract (Figure 20A). This band intensity increased in a nuclear protein 
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concentration-dependent manner (Figure 20B), indicating that there is 
nuclear protein binding to the probe in RA-dependent manner. Next, to 
confirm cell division-dependent binding, the probe was incubated with RA-
treated nuclear extracts in the presence of thymidine (Figure 20C). The result 
was consistent with qPCR and luciferase assay in that the retarded band in 
RA-treated group disappeared when mixed with extract from cells whose cell 
division was blocked by thymidine.  
To identify candidate transcription factor, it was necessary to further 
minimize the binding region. The 50 bp region was sub-divided into two 
regions and EMSA assay was performed to see if the binding occurs in a 
specific 25 bp region. The result showed that the binding occurs only in a -
1250/-1225 region (Figure 21A). Using this region, time-course EMSA assay 
was performed to see if the RA-induced binding occurs in a cell-division 
dependent manner (Figure 21B). Consistent with the time-course Tshz1 
qPCR result, the binding band was started to be observed from 18 hours post 
RA-treatment, implying the binding is not only RA-dependent, but also 
requires cells to undergo at least one round of cell division.       
Next, sequence of -1250/-1200 region was analyzed to make a list of 
possible binding transcription factors using PROMO3.0 computational 
analysis. The prediction list contained about 17 candidates. Interestingly, the 
consensus binding sequences of the candidates shared three common regions 
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within -1250/-1200 sequence. Therefore, these three regions (A, B, and C) 
common sequences were mutated (purine to pyrimidine) and the mutants 
were tested for nuclear protein-binding ability using EMSA assay (Figure 
22A). The results showed that probe with region A mutation and region B 
mutation both failed to show shifted band but region C mutation still showed 
binding band, meaning regions A and B are important for binding with 
candidate nuclear factors (Figure 22B,C). Furthermore, Tshz1 promoter -
1250/-1200 containing the mutation was tested for promoter activity via 
luciferase assay (Figure 22D) and the result showed decreased activity that 
was reduced by half compared to the wildtype. From these results, I decided 
to focus on the candidates that were predicted to bind to these two regions.  
 
E2F1 may be transcription factor that regulates Tshz1 
expression in a RA and cell division-dependent manner in P19 
cells 
Mutation analysis using EMSA assay showed that GCCGCG 
sequence within -1250/-1200 region is important for candidate binding. 
Recently, similar approach of promoter analysis and identification of binding 
factor study was published. The study showed that CCGGGCGGCCGG 
sequence of HOXB9 promoter is responsible for transcriptional activation by 
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E2F1 (Zhussupova et al., 2014). Because these two sequences were similar 
to each other, E2F1 was chosen as a candidate among the list. E2F1, a 
transcriptional activator important for progression through the G1/S 
transition, was also functionally most linked to cell division among the list 
since it is known to be required for cell proliferation (Wu et al., 2001). 
Several members of E2F family were known to be required for other types of 
differentiation, such as adipogenesis (Fajas et al., 2002). First, the binding 
ability of E2F1 to Tshz1 promoter’s regulatory region -1250/-1200 was 
tested in vitro via EMSA supershift assay using E2F1 antibody (Figure 23). 
When RA-treated nuclear extract and probe were mixed with monoclonal 
antibody specific to E2F1, a strong supershift band was observed, implying 
that E2F1 might be one of the binding proteins present in the RA-treated 
nuclear extract.  
Next, it was tested whether E2F1 is a transcription factor that 
activates endogenous Tshz1 expression in a RA-dependent manner. To do 
this, mouse E2F1 was overexpressed in P19 cells and endogenous Tshz1 
transcriptional activation was examined via qPCR (Figure 24A,B). qPCR 
results showed that endogenous Tshz1 mRNA transcript level was 30% 
higher than the mock control when RA-treated P19 cells were 
overexpressing E2F1 (Figure 24B). Having seen the enhanced Tshz1 
transcription by E2F1 overexpression, the effect of E2F1 depletion on Tshz1 
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expression was tested in parallel. Three siRNAs each targeting different 
sequence of endogenous E2F1 were used to deplete endogenous E2F1 and 
their knockdown efficiencies were confirmed by immunoblot (Figure 24C). 
qPCR analysis was performed to see the changes in endogenous Tshz1 
transcript level. The result was consistent with overexpression result in that 
Tshz1 transcript level was decreased by 30% compared to the siCTL group in 
RA-treated P19 cells. 
Next, it was tested whether E2F1 also activates Tshz1 promoter 
activity in RA-treated P19 cells by luciferase assays. Similar to qPCR result, 
Tshz1 promoter activity was enhanced when cells were overexpressing E2F1 
(Figure 25A,B). However, E2F1 overexpression had no effect on the 
promoter activity of Tshz1 mutant that has mutation at a site where E2F1 is 
predicted to bind (Figure 25B). Overall, the enhanced transcriptional 
activation of Tshz1 by E2F1 overexpression was observed with or without 
RA but the level of increase was much higher when cells were treated with 
RA.  
Similarly, the effect of E2F1 depletion on Tshz1 promoter activity 
was tested. Using P19 cells stably expressing luciferase constructs, E2F1 
depletion resulted in significantly reduced promoter activity of Tshz1-1500/+500 
and Tshz1-1250/-1200 but had no effect on luciferase activity of Tshz1-
1200/+500and Tshz1Mut (Figure 25C,D). These results indicate that E2F1 
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enhances Tshz1 transcription possibly by activating its promoter activity.  
Having confirmed E2F1’s RA-dependent activation of Tshz1, I then 
sought to see if this effect was occurring in a cell division-dependent manner 
(Figure 26). To do this, I examined change in Tshz1 promoter activity when 
cell divisions of E2F1-overexpressed (Figure 26A,B) or depleted (Figure 
26C,D) cells were blocked by thymidine treatment. Luciferase assay results 
showed that Tshz1 transcript level was reduced by half when cell division 
was blocked even if E2F1 was overexpressed. Also, E2F1 depletion did not 
further reduce Tshz1 promoter activity when cell division was blocked by 
thymidine. These results imply that effect of E2F1 on Tshz1 promoter 
activity requires cell division in RA-treated P19 cells. 
To further validate the role of E2F1 as transcription factor of Tshz1, 
I tested to see if Tshz1 promoter is occupied by E2F1. To see the direct 
binding of endogenous E2F1 to Tshz1 promoter in vivo, chromatin 
immunoprecipitation assay (ChIP) using ChIP grade E2F1 antibody was 
performed (Figure 27). The result showed that E2F1 is chromatin-
immunoprecipited with Tshz1 promoter, which was strongly enhanced when 
cells were treated with RA. To further confirm, I used three different sets of 
primers, one targeting coding region of Tshz1 (Figure 27A) and two targeting 
promoter regions of Tshz1 (Figure 27B), when amplifying Tshz1 gene from 
chromatin sample immunoprecipitated with E2F1 antibody. The results were 
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all consistent in that Tshz1 gene was amplified in RA-dependent manner 
regardless of the primer targeting different regions of the promoter. To verify 
that the result was specific to Tshz1 gene, I have also used the same ChIP 
samples to check the level of known targets of E2F1 (Figure 27C). The PCR 
result indicated that E2F1's known targets were also amplified in P19 cells 
but in RA-independent manner.  
Next, ChIP assays were performed to see if endogenous E2F1 
directly binds to Tshz1 promoter in a RA and cell division-dependent manner. 
Cell division was blocked by thymidine treatment and it was tested whether 
E2F1 can still bind to Tshz1 promoter (Figure 28A). The ChIP result using 
cell division-blocked P19 cells and E2F1 antibody showed the reduction of 
E2F1 binding to Tshz1 promoter. Time-course ChIP assay also showed that 
E2F1 binds to Tshz1 promoter in a time-dependent manner, implying that 
E2F1 may require cell division in order to efficiently bind to Tshz1 promoter 
in a RA-dependent manner (Figure 28B). Altogether, these results indicate 
that active cell division is required for E2F1 to activate Tshz1 transcription in 
a RA-dependent manner. Overall, qPCR, luciferase, and ChIP assays suggest 
that E2F1 may act was transcription factor for Tshz1, triggering Tshz1 

























Figure 5. Time-course analysis of cell division in RA-treated P19 cells. 
P19 cells were treated with 1µM of RA and cultured up to 4 days.(A) The 
number of cells were counted at each day. (B) The cells were immunostained 
with the phospho-histone H3 antibody (pHH3). The number of pHH3-
positive cells were counted. Data are shown as means ± S.D. (n = 3) and 








Figure 6. Expression of pluripotency and lineage-specific markers 
during neuronal differentiation in RA-treated P19 cells. (A-D) At 
indicated time points after RA treatment, the P19 cells were subjected to 
qPCR analysis with primers specific to selective pluripotency (Oct3/4 and 
































Figure 7. Time-course analysis of cell cycle profile in RA-treated P19 
cells. (A) P19 cells were treated with RA and cultured up to 96 h. At 
indicated time points, the cells were subjected to FACS analysis to determine 
cell cycle stages. Data are shown as means ± S.D. (n = 3). Percentage of G1 
phase cells are analyzed by One-way ANOVA with Tukey post hoc test, and 
bars marked with different letters are statistically different from each other. 
(B) P19 cells were treated with RA and cultured up to 96 h. Immunoblot 
analysis of p27Kip1each day. GAPDH was used as a loading control. 



















Figure 8. Experimental scheme of neurite outgrowth assay in P19 cells. 
Picture summarizes procedure for neurite outgrowth analysis performed in 
figure 5,6,7, and 12. RA-treated P19 cells undergo EB formation. Then, cells 
are dissociated and replated onto poly-L-lysine coated dish with B27 
supplemented media to enforce the cells to become neurons for at least 3 
days. Neurons are marked by immunostaining with Tuj1 antibody. Neurite 
length and branching are quantified using Neuron J program. Projection that 



















Figure 9. Time-course neurite formation and neuron maturation in RA-
treated P19 cells. P19 cells were treated with RA and cultured up to 96 h. 
The cells were replated and enforced to form neurites for 3 days and 
immunostained with antibody against Tuj1 (green). DNA was stained with 


















Figure 10. Time-course neurite outgrowth analysis of neurons in RA-
treated P19 cells. P19 cells were treated with RA and cultured up to 96 h, 
followed by neuronal differentiation for 3 days. Neurites of Tuj1-positive 
neurons were analyzed by quantifying their number of cells with neurites (A), 
length (B), and branches (C) using Neuron J. Greater than 100 cells were 
quantified. (A) Tuj1-positive cells with extension formed from the cell body 
that is at least twice the cell body diameter was defined as primary neurite. 
(B) Primary neurite length was quantified using Neuron J, which was divided 
by total number of cells with neurites. (C) Branch formation was quantified 
by counting neurites that are extended from primary neurite. Average 
number of branches was calculated by dividing total number of branches by 
total number of cells with primary neurites. Data are shown as means ± S.D. 





































Figure 11. Effect of cell division block during early hours post RA 
induction on neurogenesis in RA-treated P19 cells. P19 cells were induced 
with RA in the presence of thymidine for 24 or 48 h. (A) The number of cells 
with primary neurites were counted and statistically analyzed. Greater than 
100 cells were quantified. Data are shown as means ± S.D. (n = 3). *** 
p<0.001. Student t test. (B) Cells were immunostained with Tuj1 antibody 
and DAPI for DNA staining. Representative images of three independent 












Figure 12. Summary of Part 1. The picture summarizes the results from 
Figure 1 to Figure 7. Analysis of cell cycle dynamics during neuronal 
differentiation suggests that at least 48 hours after RA treatment is needed 
for cells to differentiate into neurons. Cell division block using thymidine 
shows that cell division during early stage is important for neuronal 






























Figure 13. Experimental scheme of screening for cell division-dependent 
genes during early hours after RA treatment in P19 cells. P19 cells are 
synchronized by single thymidine block. Then, upon drug release, cells are 
grouped into four. In groups without RA induction, cells are either treated in 
the presence or absence of thymidine to see if the drug itself caused changes 
in the expression of genes. In groups treated with RA, cells are not treated 
with cell cycle blocking drug to see if the candidate gene is induced by RA. 
For cells treated with RA and thymidine, they are tested to see if their 


















Figure 14. Summary of screening for candidate genes that are under cell 
division-dependent transcriptional control. (A) P19 cells were treated 
with RA for 24 h in the presence of thymidine, and subjected to RT-PCR 
analysis with primers specific to Stra8. (B) RT-PCR analyses were 























Figure 15. Tshz1 is RA-induced gene that may be regulated in cell 
division-dependent manner. (A) P19 cells were treated with RA and RNA 
samples were harvested at indicated time points. RT-PCR analysis of Tshz1 
was performed. Beta-actin transcript level was used as a loading control. (B) 
P19 cells were treated with RA for 24 h in the presence of thymidine or 
RO3306, and subjected to qPCR analysis for Tshz1 expression. Data are 
shown as means ± S.D. (n = 3). * p< 0.05, ** p<0.01, *** p<0.001. Student t 
test. (C) Synchronized P19 cells were RA-treated and cultured up to 24 h. 
Thymidine was also treated for 24 h. At indicated time points, the cells were 
harvested and subjected to qPCR analysis for Tshz1expression. The values 











Figure 16. Tshz1 depletion results in defect of neurite formation in RA-
treated P19 cells. (A) Experimental scheme for neurite outgrowth assay 
with Tshz1 depletion using siRNA. siRNA was treated twice, before and after 
neuronal differentiation. (B) P19 cells were transfected with siTshz1 for 48 h 
and subjected to qPCR with primers specific to Tshz1. (C) The cells were 
immunostained with Tuj1 (green) antibody. DNA was stained with DAPI 
(blue). Scale bar, 10µm (D) Neurite outgrowth analysis of cells with Tshz1 
depletion. Percentage of neurite positive cells were quantified using Tuj1 
immunostaining results and Neuron J. Data are shown as means ± S.D. (n = 










Figure 17. Promoter study of Tshz1 in RA-treated P19 cells. (A) Diagram 
of genomic loci and cloned promoter region of Tshz1for the following 
promoter studies. -1500 bp relative to transcription start site (TSS) of Tshz1 
gene was cloned from P19 cells and subcloned into pGL3 luciferase vector. 
(B) Luciferase activity of Tshz1 promoter in P19 cells. From-1500 bp to 
+500 bp region was linked to luciferase gene. P19 cells were stably 
transfected with the Tshz1-luciferase construct. Cells were treated with RA 
for 24 h in the presence of thymidine and subjected to luciferase assay. 
Luciferase activity of Tshz1 promoter was measured relative to pGL3 vector 
that has basal luciferase activity. Data are shown as means ± S.D. (n = 3). 





Figure 18. Identification of Tshz1 promoter region that is essential for 
RA-induced transcriptional activation. (A) The luciferase gene was linked 
to the Tshz1 promoter sequences up to -1500 bp. P19 cells were stably 
transfected with indicated Tshz1-luciferase constructs. (B) Fragments of the 
Tshz1 promoter within -1400/-1200 region were linked to TK-luciferase 
constructs. P19 cells were stably transfected with the indicated Tshz1-TK-
luciferase constructs. (A-B) Cells were treated with RA for 24 h and 
subjected to luciferase assay. Luciferase activity of Tshz1 promoter was 


















Figure 19. -1250/-1200 of Tshz1 promoter region is essential for RA and 
cell division-dependent transcriptional activation. P19 cells were stably 
transfected with the indicated Tshz1-TK-luciferase constructs. Cells were 
treated with RA for 24 h in the presence of thymidine and subjected to 
luciferase assay. Luciferase activity of Tshz1 promoter was measured relative 










Figure 20. EMSA analysis with the Tshz1 promoter-1250/-1200 sequence. (A) 
EMSA assay was performed using -1250/-1200 of the Tshz1 promoter as a 
probe. The cytoplasmic and nuclear extracts were prepared from P19 cells 
treated with RA for 24 h. Arrowhead indicates specific retarded band. (B) 
EMSA assay was performed with nuclear extract of P19 cells. As a 
competitor, excess amount (100 fold) of the cold probe was added into the 
reaction mixture. Increasing amount of nuclear extracts (4-24 μg protein) 
was added into the reaction mixture. (C) Nuclear extracts were prepared 
from RA-treated P19 cells which had been cultured in the presence of 

































Figure 21. Tshz1 promoter-1250/-1225 is essential for RA and cell division-
dependent binding of candidate nuclear factor. (A) EMSA assay was 
performed using three different sequences as a probe with nuclear extract of 
P19 cells that was RA-treated for 24 h. Competitor is a cold probe with same 
sequence as the indicated probe. (B) Time-course EMSA assay was 
performed using -1250/-1226 as a probe. Nuclear extracts of P19 cells 
treated with RA for indicated number of hours were each mixed with the 













































Figure 22. Mutation analysis of Tshz1 promoter-1250/-1200 (A) Scheme 
showing potentially important sequences within -1250/-1200. Each region is 
labeled as either A, B, or C. Three different probes each containing mutation 
in either region are describe. The sequences of the mutants are indicated on 
the right side. (B) Wildtype with no mutation and three different mutants are 
used as probes. EMSA assay was performed using the indicated probes with 
nuclear extract of P19 cells that is RA-treated for 24 h. Arrowhead indicates 
specific retarded band. (C) Two probes, one with -1250/-1200 region and the 
other with -1250/-1226 region are used for EMSA assay. Probes are mixed 
with four different cold probes. Arrowhead indicates specific retarded band. 
(D) P19 cells were stably transfected with Tshz1-TK-luciferase construct 
containing mutation at -1246/-1241 region. Data are shown as means ± S.D. 


































Figure 23. EMSA supershift analysis with the Tshz1 promoter-1250/-1200 
sequence and E2F1 antibody. EMSA assay was performed with Tshz1 
promoter-1250/-1200 as a probe. Nuclear extracts were prepared from the RA-
treated P19 cells. Indicated amounts of the E2F1 antibody were added in the 





Figure 24. E2F1 enhances endogenousTshz1 transcription in RA-treated 
P19 cells. (A-B) P19 cells were transiently transfected with indicated 
plasmids for 24 h. (A) Protein level of transiently overexpressed flag-tagged 
E2F1. GAPDH protein level was used as loading control. (B) Transiently 
E2F1-overexpressing P19 cells were treated with RA for 24 h. Total RNA 
was extracted and subjected to qPCR to measure the endogenous Tshz1 
transcript level. mRNA level was normalized by the level of GAPDH and 
calculated as relative to –RA mock control group. (C-D) P19 cells were 
transfected with siRNA for 48 h. (C) Protein level of E2F1 was measured by 
immunoblot, and alpha-tubulin protein level was used as loading control. (D) 
E2F1-depleted P19 cells were treated with RA for 24 h. Total RNA was 
extracted and subjected to qPCR to measure the endogenous Tshz1 transcript 
level. Data are shown as means ± S.D. (n = 3). Data are analyzed by One-
way ANOVA with Tukey post hoc test, and bars marked with * are 











Figure 25. E2F1 promotes Tshz1 promoter activity in RA-treated P19 
cells. P19 cells were stably transfected with indicated Tshz1 promoter 
constructs. (A-B) Transiently E2F1-overexpressing P19 cells were treated 
with RA for 24 h. (C-D) E2F1-depleted P19 cells were treated with RA for 
24 h. Luciferase activity of (A,C) Tshz1 promoter-1500/+500and (B,D) Tshz1 
promoter-1250/-1200 when RA-treated P19 cells had overexpressed or depleted-
E2F1. Data are shown as means ± S.D. (n = 3). Data are analyzed by One-
way ANOVA with Tukey post hoc test, and bars marked with * are 













Figure 26. E2F1 may regulate Tshz1 promoter activity in a cell division-
dependent manner in RA-treated P19 cells. P19 cells were stably 
transfected with indicated Tshz1 promoter constructs and treated with RA in 
the presence of thymidine for 24 h. (A-D) Luciferase assay result of (A,C) 
Tshz1 promoter-1500/+500 and (B,D) Tshz1 promoter-1250/-1200 in E2F1-
overexpressed or E2F1-depleted cells. Data are analyzed by One-way 
ANOVA with Tukey post hoc test, and bars marked with * are statistically 














Figure 27. E2F1 directly binds to Tshz1 promoter in RA-dependent 
manner in P19 cells in vivo. (A-C) Nuclear extracts were prepared from 
P19 cells which had been treated with RA for 24 h. (A) ChIP-PCR analysis 
was performed with E2F1 antibody and PCR using primers specific to a 
coding sequence of Tshz1. (B) ChIP-PCR analysis was performed with 
primers for -1.5/-1.1 and -0.9/-0.5 of the Tshz1 promoter. (C) ChIP-PCR 


















Figure 28. E2F1 directly binds to Tshz1 promoter in cell division-
dependent manner in RA-treated P19 cells in vivo. (A-B) Nuclear extracts 
were prepared from P19 cells which had been treated with RA up 24 h. (A) 
P19 cells were treated with RA in the presence of thymidine for 24 h. ChIP-
PCR analysis was performed with E2F1 antibody and PCR using primers 
specific to -1.5/-1.1 region of Tshz1 promoter. (B) Nuclear extract was 
prepared at indicated time points after RA treatment. ChIP-PCR analysis was 
performed with E2F1 antibody and target regions were amplified using 



















Figure 29. Model. Cell divisions after RA-induced neuronal differentiation 
in P19 cells are required for formation of neurons. E2F1 is one of 
transcription factors that may act in cell division-dependent manner to 
activate its downstream target gene, Tshz1, which is also important for 





































In this study, the main goal was to find direct evidence on the link 
between cell division and differentiation. Using RA-induced neuronal 
differentiation system of P19 cells, I propose that cell division during early 
hours of RA induction is necessary for expression of genes that are important 
for neurogenesis. By screening for RA-induced genes that cannot be induced 
without cell division during the early hours, I was able to discover several 
genes that are regulated in a cell division-dependent manner. One of the 
genes, Tshz1, a product of which is zinc finger DNA-binding transcription 
factor that is known to be important for early development in several species, 
was selected for in-depth study. Promoter analysis revealed a specific region 
that is required for RA-dependent transcription. Sequence mutation and 
computational prediction analysis listed potential upstream transcription 
factors for Tshz1. Finally, I show that E2F1, a transcription factor important 
for G1/S transition, positively regulates Tshz1 transcription in a RA and cell 
division-dependent manner by physically binding to its promoter.  
Thymidine and RO3306, drugs that arrest cell cycle at S and G2 
phase, respectively, by interfering with different pathways, are used to block 
cell division throughout the study. The main technical shortfall of the method 
is using pharmacological means to control cell division. One of the reasons 
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for this is that cell cycle and cell division are intricately regulated process 
that are connected to other major cellular process, such as cell growth, DNA 
replication, and cell death. Possibility that drug treatments could have not 
only blocked cell division, but also affected other pathways should always be 
taken into consideration when making conclusions from these data. 
Nevertheless, I have used the same drug treatment condition for various 
assays in the study and produced consistent results.  Also, I frequently 
supported data from experiments using these drugs with time-course assays 
to confirm the cell division-dependency. The study needs more natural 
setting to examine the pathway controlled by cell division, which could be 
done using FUCCI cell line in the future. 
In this study, I used total cell counting, FACS, and well-known cell 
cycle-related markers to examine cell division-related changes during RA-
induced neuronal differentiation. These data collectively suggest that cells 
are actively undergoing cell division until 48 hours after RA induction, after 
which cell division dramatically decreases and cell cycle arrest increases on 
a population level. Time-course assay of pluripotency and lineage specific 
markers showed that differentiation status change with similar pattern. These 
overall patterns of cell cycle dynamics and differentiation suggested that 
subcellular changes during early stage might be important for neuronal 
differentiation. In order to test this projection, direct correlation between the 
81 
 
events within the same cell should be examined in detail, nevertheless, 
similar time-course assays were reported using hESCs in vitro differentiation 
system. It was observed that earliest implementation of differentiation into 
NE (neuroectoderm) involves restructuring of the cell cycle (Jang et al., 
2016). If possible, it would be interesting to see what portions of cells are 
undergoing these changes and which cell division-related events determine 
these variations despite the same environment during differentiation.   
Due to limitations on obtaining good quality Tshz1 antibody, the 
study could not fully explain how Tshz1 might play role during neuronal 
differentiation in P19 cells. Tshz1’s potential role during differentiation can 
be inferred from its function in other tissue development. Tshz1 was 
suggested as downstream target of Pdx1 during beta pancreatic cell 
differentiation (Raum et al., 2015). Through analysis of Tshz1 knockout mice, 
the group suggested that Tshz1 may regulate beta-cell maturation but not 
endocrine progenitor expansion.  In CNS, a group found that Tshz1 was 
necessary for migration of neuroblasts in the OB as well as for differentiation 
of granule cells and a subclass of periglomerular interneurons (Ragakocova 
et al., 2016). These studies imply that Tshz1 might have innate character to 
promote undifferentiated cells and acquire its cell fate, possibly by being 
involved in controlling its downstream transcription network. 
There is a high possibility that E2F1 is not a sole upstream activator 
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of Tshz1. E2F1 knockdown does not completely abolish endogenous Tshz1 
transcription and other predicted candidate transcription factors still need to 
be tested in the future. Also, there has been a study showing that Tshz1 is 
induced by RA in mouse embryo and that it can be chromatin-
immunoprecipitated by RAR-gamma (Savory et al., 2014) but the binding 
region was about -9Kb upstream relative to TSS. This suggests that there are 
other upstream regulators for Tshz1 transcription in RA-dependent manner 
during development.          
E2F1 is a well-known cell cycle-regulating transcription factor, the 
activity of which is regulated by retinoblastoma protein family during G1 
phase. In addition to its role during conventional cell cycle, the involvement 
of E2F1 during tissue development and stem cell differentiation has been 
suggested by several previous studies. Studies on E2F1 deficient mice brain 
showed decreased stem cell and progenitor division in the proliferative zones 
of the lateral ventricle wall and the hippocampus in postnatal brain 
(Christiana et al., 2002). Reduction in neuronal cell numbers due to lack of 
E2F1 was observed in granule cells in the olfactory bulb, dentate gyrus, and 
cerebellum. During early germ layer specification in hESCs, E2F1 was found 
to form complex with cyclin D1 on endoderm promoters (Pauklin et al., 
2015). The functional significance was that E2F1 may be involved in 
transcriptionally repressive interaction with cyclin D1 in late G1 phase. In 
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the case of early pancreas development, Cdk4 was found to be important for 
expansion of Pdx1+ pancreatic progenitor cells. E2F1 was implied as Cdk4-
mediator, which promotes beta cell progenitor expansion by transcriptionally 
activating Ngn3 promoter (Kim and Rane, 2011). Also, several E2F family 
members were examined during adipogenesis using 3T3-L1 cell line. The 
study revealed that E2F4 plays repressive role, whereas E2F1 exerts 
activation of PPAR-gamma expression upon the initiation of mitotic clonal 
expansion (Fajas et al., 2002). Similar to the implications of my study, 
discovery of transcriptional role played by E2F1 during adipogenesis was 
represented as the mechanistic link between proliferative signaling pathway 
and steps involved in adipocyte differentiation.  
Despite these previous studies that support the potential role of E2F1 
during early stages of neuronal differentiation in RA-induced P19 cells, 
additional experiments are required to fully understand the involvement of 
E2F1. For example, E2F1 activation is known to require heterodimerization 
with DP (dimerization protein) family members (Poppy Roworth et al.,2014). 
Depending on the type of heterodimerization that is formed, it forms larger 
complex containing retinoblastoma family members, which directs E2F1 
either to activate or repress its target genes (Dimova and Dyson, 2005). 
Therefore, it is important to examine with which coregulators E2F1 form 
heterodimer and whether or not other members of E2F family is involved in 
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Tshz1 transcription.  
Important question that arises from the study is how E2F1 regulates 
Tshz1 transcription in cell division-dependent manner. ChIP assay and 
EMSA supershift assay both suggest that E2F1 binds to Tshz1 promoter 
region in a sequence-specific manner but this does not explain how E2F1 
recognizes Tshz1 to be its downstream target by coordinating with cell 
division. E2F1 is well characterized protein that is important for cell 
proliferation even in non-differentiating cells. It is known that all members 
of E2F family proteins require dimerization partners either to activate or 
repress their target genes (Fajas et al., 2002; Poppy Roworth et al., 2017). 
E2F1 may switch its sets of target genes by interacting with different 
partners depending on upstream cues. It has been investigated that E2F1 
recruits HAT (histone acetyl transferase) to local chromatin, which results in 
gene expression control (Kheir and Lund, 2010). In this way, E2F1 may 
function during differentiation but in a context specific and cell type specific 
manner, possibly by dimerizing with different factors (Dimova and Dyson, 
2005).  
What is the biological significance of linking differentiation to cell 
cycle progression? Cell fate is achieved by expressing specific genes that are 
required for acquiring a specific identity of the cell. One of the direct ways 
which control these gene expressions is by altering epigenetic status that 
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globally regulates which genes to be turned on or off. Differentiation, a 
process by which stem cells acquire its final cell fate, accompanies this high 
level of gene expression changes via chromatin remodeling. During normal 
cell cycle, epigenetic marks are transiently erased during S phase to duplicate 
genes as well as histones that comprise chromatin to produce identical 
daughter cell with same epigenetic state. In this way, progression through the 
cell cycle during differentiation allows the cell to undergo chromatin 
remodeling to regulate gene expression. Because changes in global 
transcriptome during differentiation require chromatin restructuring, 
differentiation is tightly linked to cell cycle phase, which allows for re-
establishment of histones (Ma et al, 2015).  
The link between cell cycle-dependent epigenetic changes during 
differentiation has been recently investigated by several reports. A group has 
shown that G1 phase-expressed genes are heavily enriched for roles in 
development and cell-fate commitment. This change in gene expression was 
found to be linked to the cytosine modification 5-hydroxymethylcytosine 
(5hmC), which was increased during late G1 and re-established during G2 
phase (Singh et al., 2013). This and other recent studies imply that there 
might be a cell cycle-regulated active chromatin restructuring during S phase 
of stem cell differentiation. Although this idea has not been tested in depth, 
there might be a layer of system that controls chromatin remodeling through 
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cell division, thereby efficiently controlling homogenous gene expression 
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 세포주기의 진행은 미분화된 줄기 세포의 운명을 결정짓는 
과정과 맞닿아 있다. 따라서 세포 분열은 줄기세포의 분화가 
정상적으로 진행되는 데에 필요한 주요인자 중 하나로 볼 수 있는데, 
예를 들어 지방세포 분화 과정 동안 mitotic clonal expansion (MCE) 
에 대한 연구를 통해 그 중요성이 시사 된 바 있다. 하지만 세포분열이 
조직발생 및 항상성 유지를 위하여 다양한 분화과정에서 역할을 
하는지 여부에 대해서는 심도있는 이해가 부족하다. 이와 같이 
세포분열과 분화에 대한 연관 관계가 있음에도 불구하고 
분화과정에서 세포분열의 직접적인 역할과 작용기전에 대해서는 
알려진 바가 없다. 본 연구에서는 신경세포로의 분화과정 동안 
세포분열의 역할에 대하여 연구하였다. 이를 위해 레티놀산 (retinoic 
acid) 로 신경세포분화를 유도한 P19 세포주의 in vitro 분화 
시스템을 이용하여 세포분열과 신경세포분화과정의 직접적인 
관계여부를 확인하고자 하였다. 이를 위해 세포분열을 저해하는 약을 
처리하였을 때 P19 세포가 신경세포로 분화하지 못하는 것을 
관찰하였다. 본 현상에 대한 기전을 연구하기 위해 세포분열 저해제를 
처리하였을 때 발현이 저해되는 유전자를 스크리닝 하여 Tshz1 이 
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세포분열 의존적으로 발현됨을 확인 할 수 있었다. Tshz1 의 
촉진유전자를 클로닝하여 발현에 필수적인 부위를 분석한 결과, 
Tshz1 의 특정 부위가 P19 세포에서 레티놀산 그리고 세포 분열 
의존적으로 발현되는 데에 중요함을 알 수 있었다. 컴퓨터 
프로그래밍을 이용해 동정한 특정 부위의 서열을 분석하여 Tshz1 의 
전사인자로 작용 가능한 후보군을 설정하였는데, 이전 보고된 
논문들을 기반하여 E2F1 이 Tshz1 의 전사인자로 작용할 수 있는 
가능성을 확인하였다. 이것을 실험해보기 위해 E2F1 의 발현을 
억제하거나 과발현 한 후 Tshz1 의 발현 정도를 다양한 방법을 통해 
확인한 결과, E2F1 이 Tshz1 의 전사인자로 작용할 수 있음을 알 수 
있었다. 또한 약 처리를 통해 세포분열을 저해하였을 때 E2F1 이 
Tshz1 의 유전자에 결합하여 전사인자로 작용하는 효과가 
감소하였다. 종합적으로 신경세포분화과정 동안 세포 분열은 E2F1 
전사인자로의 작용을 통하여 하위 유전자인 Tshz1 의 발현을 
조절하고 이러한 일련의 과정을 통해 신경세포분화에 중요한 역할을 
함을 알 수 있었다. 본 연구는 세포 분열 의존적으로 조절되는 
유전자의 동정과 상위 기전을 규명함으로써 세포분열이 
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